NatureWise Biotech & Medicals Corporation logo

NatureWise Biotech & Medicals Corporation (4732)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
16. 35
-0.1
-0.6079%
NT$
- Market Cap
18.05 P/E Ratio
82.4% Div Yield
17,426 Volume
0 Eps
NT$ 16.45
Previous Close
Add Transaction
Day Range
15.9 16.45
Year Range
15.25 24.6
Want to track 4732 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

NatureWise Biotech & Medicals Corporation (4732) Statistics

Valuation metrics

Market Cap -
Enterprise value 685.38M
Trailing P/E (ttm) -8.44
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 4.36
Price/Book (mrq) 1.24
Enterprise Value/Revenue 3.88
Enterprise Value/EBITDA -7.15

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 15.21K
Average volume (90 days) 15.57K

Price summary

52-Week low 15.25
52-Week high 24.6
Beta -
50-Day moving average 16.88
200-Day moving average 18.72

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 1,060:1,000
Last split Date 13 Sep 2021

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.52%
Operating margin -0.6%

Operational effectiveness

Return on assets -0.13%
Return on equity -0.14%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 3.64
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.9
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 9.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 10.66%
Book value per share (mrq) 13.18

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -